The Implantable Cardioverter Defibrillator: Technical and Clinical Considerations

2013 
The implantable cardioverter defibrillator (ICD) has become the most common device implanted for the treatment of arrhythmia disorders. The enormous technological development of these devices is perhaps the most dramatic progression observed in medicine over the last 30 years. The initial experiments of Mirowski published in 1978 required an external unit developed into epicardial patches and a large abdominal human implantable device released in 1985 and this yielded to transvenous leads in the early 1990s and smaller pectoral and dual chamber devices in the late 1990s and ultimately to combine cardiac resynchronization devices with defibrillation in the first few years of the new millennium.
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    58
    References
    2
    Citations
    NaN
    KQI
    []